Companies: 10,795·Total market cap: $144.5T
Bioasis Technologies Inc.

Bioasis Technologies Inc.

BIOAFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$7941
P/E Ratio
52W High$0.0002
52W Low$0.0001

Bioasis Technologies Inc.(BIOAF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BIOAF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-022021-022020-022019-022018-02
Revenue
Revenue$0.04M$4.08M$0.61M$1.42M$0.59M
Cost of Revenue$1.23M$1.24M$0.00M$0.01M$0.47M
Gross Profit($1.19M)$2.84M$0.61M$1.41M$0.12M
Gross Margin %(computed)69.64%100.00%99.27%20.68%
Operating Expenses
R&D Expenses$1.23M$1.24M$2.03M$1.95M$0.95M
G&A Expenses$2.41M$2.46M$3.17M$4.31M$4.45M
Total Operating Expenses$3.63M$3.70M$5.21M$6.27M$5.40M
Operating Income($4.82M)($0.86M)($5.19M)($6.24M)($5.24M)
Operating Margin %(computed)-21.04%-856.53%-438.75%-887.56%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.01M
Interest Expense$0.65M$0.00M$0.05M$0.00M$0.00M
Income Before Tax($2.96M)$0.70M($4.06M)($3.47M)($5.31M)
Income Tax Expense$0.00M$0.00M$0.00M($1.38M)$0.03M
Net Income($2.96M)$0.70M($4.06M)($3.47M)($5.31M)
Net Margin %(computed)17.13%-668.95%-244.26%-899.89%
Per Share & EBITDA
EPS (Basic)$-0.04$0.01$-0.07$-0.06$-0.10
Wtd Avg Shares72.17M68.12M62.27M56.68M50.90M
EBITDA($3.54M)$0.44M($4.54M)($4.79M)($5.22M)
EBITDA Margin %(computed)10.74%-747.99%-336.84%-885.11%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CAD · M

深入了解Bioasis Technologies Inc.

关于Bioasis Technologies Inc.(BIOAF)损益表

Bioasis Technologies Inc.(BIOAF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,BIOAF实现营收$0.00B,毛利润($0.00B)(毛利率-3150.25%),净利润($0.00B)(净利率-7846.50%)。

常见问题

BIOAF · 4 问

Bioasis Technologies Inc.(BIOAF)2022财年营收为$0.00B,同比down99.1%。

BIOAF revenueBIOAF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09